Literature DB >> 6849765

Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.

R Jochemsen, B R Van Beusekom, P Spoelstra, A R Janssens, D D Breimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6849765      PMCID： PMC1427771          DOI： 10.1111/j.1365-2125.1983.tb01502.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  34 in total

1.  Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo.

Authors:  A G Hildebrandt; I Roots; M Speck; K Saalfrank; H Kewitz
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

2.  Increased sensitivity to nitrazepam in old age.

Authors:  C M Castleden; C F George; D Marcer; C Hallett
Journal:  Br Med J       Date:  1977-01-01

3.  The effect of spironolactone on antipyrine metabolism in man.

Authors:  D H Huffman; D W Shoeman; P Pentikäinen; D L Azarnoff
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

4.  Spironolactone--a weak enzyme inducer in man.

Authors:  S A Taylor; M D Rawlins; S E Smith
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

5.  Nitrazepam and the elderly.

Authors:  J G Evans; E H Jarvis
Journal:  Br Med J       Date:  1972-11-25

6.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  Assay of underivatized intrazepam and clonazepam in plasma by capillary gas chromatography applied to pharmacokinetic and bioavailability studies in humans.

Authors:  A G de Boer; J Röst-Kaiser; H Bracht; D D Breimer
Journal:  J Chromatogr       Date:  1978-01-01

8.  Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

9.  Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.

Authors:  H J Shull; G R Wilkinson; R Johnson; S Schenker
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

10.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
View more
  12 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.

Authors:  J Sonne; S Loft; M Døssing; S Boesgaard; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 4.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 5.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

6.  Pharmacokinetics of oral brotizolam in patients with liver cirrhosis.

Authors:  R Jochemsen; R P Joeres; J G Wesselman; E Richter; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  Pharmacokinetics of brotizolam in the elderly.

Authors:  R Jochemsen; K L Nandi; D Corless; J G Wesselman; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Obesity effects on nitrazepam disposition.

Authors:  D R Abernethy; D J Greenblatt; A Locniskar; H R Ochs; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

9.  Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?

Authors:  H H Thijssen; L G Baars
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 10.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.